VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

MPN Congress 2022 | The role of BMT & clinical trials in patients with PV with multiple treatment-limiting toxicities

Joseph Scandura, MD, PhD, Weill Cornell Medicine and the New York Presbyterian Hospital, New York City, NY, highlights alternative treatment options available for patients with polycythemia vera (PV) that are experiencing multiple treatment-limiting toxicities, including clinical trials and bone marrow transplant (BMT). This interview took place at the 14th International Congress on Myeloproliferative Neoplasms (MPN Congress) held in New York City, NY.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter